Multiparametric MRI (mpMRI) is increasingly important in prostate cancer diagnosis, as it provides accurate information on tumor location, stage, and aggressiveness—beyond what traditional methods can offer. Combining anatomical and functional techniques (T2-weighted imaging, DWI, DCE, and MRSI), mpMRI improves detection and treatment planning.
At 3T, MRI achieves high accuracy, especially when using an endorectal coil, though this may cause discomfort and affect prostate shape. MRI also enables more precise approaches such as MRI-guided biopsy and focal therapies like cryoablation, which require fewer samples and show promising results.
Overall, MRI supports more accurate and personalized prostate cancer care, although further research and standardization are needed.